William Hahn
Directeur/Membre du Conseil chez Commonwealth Cancer Consortium, Inc.
Profil
Dr. William (Bill) C.
Hahn currently serves as an Advisor to MPM BioImpact.
Bill is a leading scientist and physician involved in biomedical research and in the care of cancer patients.
He is currently Chief Research Strategy Officer and Chief, Division of Molecular and Cellular Oncology at Dana-Farber Cancer Institute and is also an Institute Member of the Broad Institute.
Bill’s numerous groundbreaking discoveries have informed the current molecular understanding of cancer and have defined the tools, technologies and experimental models used to discover and validate targeted cancer therapies.
Widely recognized for his work, he was honored with the 2015 Richard and Hinda Rosenthal Award from AACR and the Ho-Am Prize in Medicine in 2010.
He serves as a medical oncologist and Professor at the Dana-Farber Cancer Institute and Harvard Medical School and is an Institute Member of the Broad Institute of MIT and Harvard.
He is also the Chief Research Strategy Officer and the Chief of the Division of Molecular and Cellular Oncology in the Department of Medical Oncology at Dana-Farber Cancer Institute.
Of his many other awards and professional affiliations, Bill received the Wilson S.
Stone Award from M.D.
Anderson Cancer Center for outstanding research in cancer and the Howard Temin Award from the National Cancer Institute; he has also served as President of the American Society for Clinical Investigation and was elected to the Association of American Physicians.
Bill earned his M.D.
and Ph.D.
from Harvard Medical School and his B.A.
from Harvard University.
He completed clinical training in internal medicine at Massachusetts General Hospital and medical oncology at Dana-Farber and conducted his postdoctoral studies in the lab of Robert Weinberg at the Whitehead Institute for Biomedical Research.
Postes actifs de William Hahn
| Sociétés | Poste | Début |
|---|---|---|
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Bioimpact Capital LLC
 Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - |
| Commonwealth Cancer Consortium, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de William Hahn
| Sociétés | Poste | Fin |
|---|---|---|
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Fondateur | - |
| THERMO FISHER SCIENTIFIC | Directeur/Membre du Conseil | - |
Formation de William Hahn
| Harvard University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| Entreprise privées | 6 |
|---|---|
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology The Broad Institute, Inc. engages in the provision of research and development in biomedicals to cure infectious disease. Its scientific areas include chemical biology and therapeutics, genome regulation, cellular circuity and epigenomics, medical and population genetics, and metabolism. The company was founded by Eric S. Lander, Eli Broad and Edythe Broad in 2003 and is headquartered in Cambridge, MA. | Health Technology |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Health Technology |
| Commonwealth Cancer Consortium, Inc. | |
Bioimpact Capital LLC
Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Finance |
